{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:11:16Z","timestamp":1793193076223,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AG054839-01A1"],"award-info":[{"award-number":["1R01AG054839-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R41AG087769-01A1"],"award-info":[{"award-number":["1R41AG087769-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA263747-01A1"],"award-info":[{"award-number":["1R01CA263747-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.celbio.2025.100158","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T14:41:04Z","timestamp":1754491264000},"page":"100158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ceria nanocluster-based therapy for Alzheimer\u2019s disease through the modulation of activated microglia and attenuation of amyloid-\u03b2 deposition"],"prefix":"10.1016","volume":"1","author":[{"given":"Hai-Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-7058","authenticated-orcid":false,"given":"Peisheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2025.100158_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd4709","article-title":"Alzheimer antibody drugs show questionable potential","volume":"14","author":"Reardon","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celbio.2025.100158_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120861","article-title":"Alzheimer's disease failed clinical trials","volume":"306","author":"Asher","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.celbio.2025.100158_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.tins.2015.08.006","article-title":"Microglial malfunction: the third rail in the development of Alzheimer's disease","volume":"38","author":"Mhatre","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celbio.2025.100158_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","article-title":"Microglia in Alzheimer's disease: A multifaceted relationship","volume":"55","author":"ElAli","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.celbio.2025.100158_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-013-1182-x","article-title":"Microglia actions in Alzheimer's disease","volume":"126","author":"Prokop","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celbio.2025.100158_bib6","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.celbio.2025.100158_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.12703\/P5-53","article-title":"Microglia - the brain's busy bees Rep 5","volume":"5","author":"Cronk","year":"2013","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.celbio.2025.100158_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7176","article-title":"Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques","volume":"6","author":"Condello","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2025.100158_bib9","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","article-title":"SYK coordinates neuroprotective microglial responses in neurodegenerative disease","volume":"185","author":"Ennerfelt","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.celbio.2025.100158_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.celbio.2025.100158_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.celbio.2025.100158_bib12","article-title":"NIR-II Hydrogen-Bonded Organic Frameworks (HOFs) Used for Target-Specific Amyloid-\u03b2 Photooxygenation in an Alzheimer's Disease Model","volume":"61","author":"Zhang","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.celbio.2025.100158_bib13","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","article-title":"Reactive Oxygen Species (ROS)-Based Nanomedicine","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.celbio.2025.100158_bib14","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.2147\/IJN.S270229","article-title":"The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.celbio.2025.100158_bib15","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2217\/nnm-2018-0318","article-title":"Superoxide dismutase mimetic nanoceria restrains cerulein induced acute pancreatitis","volume":"14","author":"Khurana","year":"2019","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.celbio.2025.100158_bib16","first-page":"4507","article-title":"Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation","volume":"8","author":"Arya","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.celbio.2025.100158_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25194559","article-title":"Cerium Oxide Nanoparticles (Nanoceria): Hopes in Soft Tissue Engineering","volume":"25","author":"Sadidi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.celbio.2025.100158_bib18","article-title":"Antioxidant mesoporous Ce-doped bioactive glass nanoparticles with anti-inflammatory and pro-osteogenic activities","volume":"5","author":"Zheng","year":"2020","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.celbio.2025.100158_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0960327119880586","article-title":"Diminished amyloid-beta uptake by mouse microglia upon treatment with quantum dots, silver or cerium oxide nanoparticles: Nanoparticles and amyloid-beta uptake by microglia","volume":"39","author":"Sikorska","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.celbio.2025.100158_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-009-0513-4","article-title":"Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease","volume":"118","author":"Wang","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celbio.2025.100158_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(00)03075-4","article-title":"Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease","volume":"888","author":"Sasaki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.celbio.2025.100158_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fnagi.2020.00217","article-title":"Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE)","volume":"12","author":"Kong","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celbio.2025.100158_bib23","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emm.2013.147","article-title":"Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celbio.2025.100158_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/acs.chemrestox.3c00378","article-title":"Silica Nanoparticle Exposure Implicates \u03b2-Amyloid (1\u201342) Inbound and the Accelerating Alzheimer\u2019s Disease Progression in Mice Overexpressing Mutated Forms of Human Amyloid Precursor Protein and Presenilin 1 Genes","volume":"37","author":"Wei","year":"2024","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.celbio.2025.100158_bib25","doi-asserted-by":"crossref","first-page":"21702","DOI":"10.1021\/jacs.0c08395","article-title":"Self-protecting biomimetic nanozyme for selective and synergistic clearance of peripheral amyloid-\u03b2 in an Alzheimer\u2019s disease model","volume":"142","author":"Ma","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.celbio.2025.100158_bib26","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/acs.accounts.1c00055","article-title":"Current strategies for modulating A\u03b2 aggregation with multifunctional agents","volume":"54","author":"Du","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.celbio.2025.100158_bib27","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1021\/nn403743b","article-title":"Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain","volume":"7","author":"Heckman","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.celbio.2025.100158_bib28","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/acsnano.8b01994","article-title":"Simultaneous blood\u2013brain barrier crossing and protection for stroke treatment based on edaravone-loaded ceria nanoparticles","volume":"12","author":"Bao","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.celbio.2025.100158_bib29","article-title":"Biomimetic nanomedicine coupled with neoadjuvant chemotherapy to suppress breast cancer metastasis via tumor microenvironment remodeling","volume":"31","author":"Liu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.celbio.2025.100158_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/mp800137z","article-title":"Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited","volume":"6","author":"Xu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.celbio.2025.100158_bib31","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer\u2019s disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.celbio.2025.100158_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuron.2015.01.021","article-title":"Anti-inflammatory signaling in microglia exacerbates Alzheimer\u2019s disease-related pathology","volume":"85","author":"Michaud","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.celbio.2025.100158_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/cns.12588","article-title":"Melatonin stimulates the SIRT 1\/Nrf2 signaling pathway counteracting lipopolysaccharide (LPS)-induced oxidative stress to rescue postnatal rat brain","volume":"23","author":"Shah","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.celbio.2025.100158_bib34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.celbio.2025.100158_bib35","article-title":"Microenvironment remodeling micelles for Alzheimer's disease therapy by early modulation of activated microglia","volume":"6","author":"Lu","year":"2019","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.celbio.2025.100158_bib36","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"A\u03b21\u201342-RAGE interaction disrupts tight junctions of the blood\u2013brain barrier via Ca2+-calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celbio.2025.100158_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2025.100158_bib38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","article-title":"The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies","volume":"107","author":"Poller","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.celbio.2025.100158_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402342","article-title":"A Biocompatible Hydrogen-Bonded Organic Framework (HOF) as Sonosensitizer and Artificial Enzyme for In-Depth Treatment of Alzheimer's Disease","volume":"13","author":"Ya","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.celbio.2025.100158_bib40","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.cclet.2018.10.003","article-title":"KLVFF peptide functionalized nanoparticles capture A\u03b242 by co-assembly for decreasing cytotoxicity","volume":"29","author":"Yang","year":"2018","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.celbio.2025.100158_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04255-z","article-title":"A self-destructive nanosweeper that captures and clears amyloid \u03b2-peptides","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2025.100158_bib42","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.biomaterials.2008.12.044","article-title":"Development of highly porous large PLGA microparticles for pulmonary drug delivery","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2025.100158_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celbio.2025.100158_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-2009-1030","article-title":"RAGE and Alzheimer's disease: a progression factor for amyloid-\u03b2-induced cellular perturbation?","volume":"16","author":"Yan","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celbio.2025.100158_bib45","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid \u03b2\u2013mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.celbio.2025.100158_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/acs.nanolett.8b03644","article-title":"Nanocomposites inhibit the formation, mitigate the neurotoxicity, and facilitate the removal of \u03b2-amyloid aggregates in Alzheimer\u2019s disease mice","volume":"19","author":"Zhao","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.celbio.2025.100158_bib47","series-title":"Stopping Alzheimer's before It Starts","author":"Miller","year":"2012"},{"key":"10.1016\/j.celbio.2025.100158_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-030-42667-5_8","article-title":"Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer\u2019s disease","volume":"1260","author":"Guest","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.celbio.2025.100158_bib49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijbiomac.2022.03.203","article-title":"Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model","volume":"208","author":"Arora","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.celbio.2025.100158_bib50","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celbio.2025.100158_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2025.100158_bib52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1096\/fj.12-208660","article-title":"Attenuating astrocyte activation accelerates plaque pathogenesis in APP\/PS1 mice","volume":"27","author":"Kraft","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.celbio.2025.100158_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70293","article-title":"TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease","volume":"21","author":"Salloway","year":"2025","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.celbio.2025.100158_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2025.100158_bib55","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celbio.2025.100158_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2020.05.044","article-title":"Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease","volume":"325","author":"Wilson","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2025.100158_bib57","doi-asserted-by":"crossref","first-page":"030902","DOI":"10.1063\/5.0013178","article-title":"Microglia-targeting nanotherapeutics for neurodegenerative diseases","volume":"4","author":"Zhao","year":"2020","journal-title":"APL Bioeng."},{"key":"10.1016\/j.celbio.2025.100158_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2025.100158_bib59","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/acs.nanolett.2c00191","article-title":"Lipoprotein-inspired nanoscavenger for the three-pronged modulation of microglia-derived neuroinflammation in Alzheimer\u2019s disease therapy","volume":"22","author":"Zhang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.celbio.2025.100158_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418560","article-title":"Hybrid Lipoplex Boosts Neuron-Microglia Crosstalk for Treatment of Alzheimer's Disease through A\u03b2-Targeted-Autophagy and ApoE2 Gene Supplementation","volume":"37","author":"Pu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2025.100158_bib61","article-title":"Tau-targeting nanoparticles for treatment of Alzheimer's disease","volume":"5","author":"Pawar","year":"2025","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.celbio.2025.100158_bib62","article-title":"Antioxidant therapy in oxidative stress-induced neurodegenerative diseases: Role of nanoparticle-based drug delivery systems in clinical translation","volume":"11","author":"Ashok","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.celbio.2025.100158_bib63","article-title":"Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases","volume":"1","author":"Zhang","year":"2021","journal-title":"Exploration (Beijing)"},{"key":"10.1016\/j.celbio.2025.100158_bib64","article-title":"Ceria-Based Therapeutic Antioxidants for Biomedical Applications","volume":"36","author":"Kim","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2025.100158_bib65","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41565-023-01523-y","article-title":"Ceria-vesicle nanohybrid therapeutic for modulation of innate and adaptive immunity in a collagen-induced arthritis model","volume":"18","author":"Koo","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celbio.2025.100158_bib66","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.cell.2023.08.037","article-title":"Human microglial state dynamics in Alzheimer\u2019s disease progression","volume":"186","author":"Sun","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.celbio.2025.100158_bib67","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","article-title":"Differential roles of M1 and M2 microglia in neurodegenerative diseases","volume":"53","author":"Tang","year":"2016","journal-title":"Mol. Neurobiol."}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562325001497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562325001497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:29:25Z","timestamp":1773052165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050562325001497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S3050562325001497"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2025.100158","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceria nanocluster-based therapy for Alzheimer\u2019s disease through the modulation of activated microglia and attenuation of amyloid-\u03b2 deposition","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2025.100158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100158"}}